The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global C13 Stable Isotope Labeled Biomolecules Market Research Report 2025
Synopsis
The global C13 Stable Isotope Labeled Biomolecules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of C13 Stable Isotope Labeled Biomolecules include Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife BV, WITEGA Laboratorien, Omicron Biochemicals and Icon Isotopes, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for C13 Stable Isotope Labeled Biomolecules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C13 Stable Isotope Labeled Biomolecules.
Report Scope
The C13 Stable Isotope Labeled Biomolecules market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global C13 Stable Isotope Labeled Biomolecules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C13 Stable Isotope Labeled Biomolecules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife BV
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes
Segment by Type
Medical C13 Stable Isotope Labeled Biomolecules
Others
Segment by Application
Scientific Research
Medical
Industrial
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of C13 Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of C13 Stable Isotope Labeled Biomolecules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global C13 Stable Isotope Labeled Biomolecules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of C13 Stable Isotope Labeled Biomolecules include Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife BV, WITEGA Laboratorien, Omicron Biochemicals and Icon Isotopes, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for C13 Stable Isotope Labeled Biomolecules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C13 Stable Isotope Labeled Biomolecules.
Report Scope
The C13 Stable Isotope Labeled Biomolecules market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global C13 Stable Isotope Labeled Biomolecules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C13 Stable Isotope Labeled Biomolecules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife BV
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes
Segment by Type
Medical C13 Stable Isotope Labeled Biomolecules
Others
Segment by Application
Scientific Research
Medical
Industrial
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of C13 Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of C13 Stable Isotope Labeled Biomolecules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 C13 Stable Isotope Labeled Biomolecules Market Overview
1.1 Product Overview and Scope of C13 Stable Isotope Labeled Biomolecules
1.2 C13 Stable Isotope Labeled Biomolecules Segment by Type
1.2.1 Global C13 Stable Isotope Labeled Biomolecules Market Value Comparison by Type (2024-2030)
1.2.2 Medical C13 Stable Isotope Labeled Biomolecules
1.2.3 Others
1.3 C13 Stable Isotope Labeled Biomolecules Segment by Application
1.3.1 Global C13 Stable Isotope Labeled Biomolecules Market Value by Application: (2024-2030)
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Industrial
1.3.5 Others
1.4 Global C13 Stable Isotope Labeled Biomolecules Market Size Estimates and Forecasts
1.4.1 Global C13 Stable Isotope Labeled Biomolecules Revenue 2019-2030
1.4.2 Global C13 Stable Isotope Labeled Biomolecules Sales 2019-2030
1.4.3 Global C13 Stable Isotope Labeled Biomolecules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 C13 Stable Isotope Labeled Biomolecules Market Competition by Manufacturers
2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturers (2019-2024)
2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global C13 Stable Isotope Labeled Biomolecules Average Price by Manufacturers (2019-2024)
2.4 Global C13 Stable Isotope Labeled Biomolecules Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of C13 Stable Isotope Labeled Biomolecules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of C13 Stable Isotope Labeled Biomolecules, Product Type & Application
2.7 C13 Stable Isotope Labeled Biomolecules Market Competitive Situation and Trends
2.7.1 C13 Stable Isotope Labeled Biomolecules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest C13 Stable Isotope Labeled Biomolecules Players Market Share by Revenue
2.7.3 Global C13 Stable Isotope Labeled Biomolecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 C13 Stable Isotope Labeled Biomolecules Retrospective Market Scenario by Region
3.1 Global C13 Stable Isotope Labeled Biomolecules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global C13 Stable Isotope Labeled Biomolecules Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2019-2030
3.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2019-2024
3.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2025-2030
3.3 Global C13 Stable Isotope Labeled Biomolecules Global C13 Stable Isotope Labeled Biomolecules Revenue by Region: 2019-2030
3.3.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region: 2019-2024
3.3.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region: 2025-2030
3.4 North America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
3.4.1 North America C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2019-2030)
3.4.3 North America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
3.5.1 Europe C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2019-2030)
3.5.3 Europe C13 Stable Isotope Labeled Biomolecules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
3.6.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Country (2019-2030)
3.6.3 Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
3.7.1 Latin America C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America C13 Stable Isotope Labeled Biomolecules Sales by Country (2019-2030)
3.7.3 Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
3.8.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2019-2030)
3.8.3 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2019-2030)
4.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2019-2024)
4.1.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2025-2030)
4.1.3 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2019-2030)
4.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2019-2030)
4.2.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2019-2024)
4.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2025-2030)
4.2.3 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2019-2030)
4.3 Global C13 Stable Isotope Labeled Biomolecules Price by Type (2019-2030)
5 Segment by Application
5.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2019-2030)
5.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2019-2024)
5.1.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2025-2030)
5.1.3 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2019-2030)
5.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2019-2030)
5.2.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2019-2024)
5.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2025-2030)
5.2.3 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2019-2030)
5.3 Global C13 Stable Isotope Labeled Biomolecules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cambridge Isotope Laboratories
6.1.1 Cambridge Isotope Laboratories Corporation Information
6.1.2 Cambridge Isotope Laboratories Description and Business Overview
6.1.3 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.1.5 Cambridge Isotope Laboratories Recent Developments/Updates
6.2 Sigma-Aldrich
6.2.1 Sigma-Aldrich Corporation Information
6.2.2 Sigma-Aldrich Description and Business Overview
6.2.3 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.2.5 Sigma-Aldrich Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Corporation Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 LGC Standards
6.4.1 LGC Standards Corporation Information
6.4.2 LGC Standards Description and Business Overview
6.4.3 LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LGC Standards C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.4.5 LGC Standards Recent Developments/Updates
6.5 Toronto Research Chemicals
6.5.1 Toronto Research Chemicals Corporation Information
6.5.2 Toronto Research Chemicals Description and Business Overview
6.5.3 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.5.5 Toronto Research Chemicals Recent Developments/Updates
6.6 IsoLife BV
6.6.1 IsoLife BV Corporation Information
6.6.2 IsoLife BV Description and Business Overview
6.6.3 IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IsoLife BV C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.6.5 IsoLife BV Recent Developments/Updates
6.7 WITEGA Laboratorien
6.6.1 WITEGA Laboratorien Corporation Information
6.6.2 WITEGA Laboratorien Description and Business Overview
6.6.3 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.7.5 WITEGA Laboratorien Recent Developments/Updates
6.8 Omicron Biochemicals
6.8.1 Omicron Biochemicals Corporation Information
6.8.2 Omicron Biochemicals Description and Business Overview
6.8.3 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.8.5 Omicron Biochemicals Recent Developments/Updates
6.9 Icon Isotopes
6.9.1 Icon Isotopes Corporation Information
6.9.2 Icon Isotopes Description and Business Overview
6.9.3 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.9.5 Icon Isotopes Recent Developments/Updates
6.10 Medical Isotopes
6.10.1 Medical Isotopes Corporation Information
6.10.2 Medical Isotopes Description and Business Overview
6.10.3 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
6.10.5 Medical Isotopes Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 C13 Stable Isotope Labeled Biomolecules Industry Chain Analysis
7.2 C13 Stable Isotope Labeled Biomolecules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 C13 Stable Isotope Labeled Biomolecules Production Mode & Process
7.4 C13 Stable Isotope Labeled Biomolecules Sales and Marketing
7.4.1 C13 Stable Isotope Labeled Biomolecules Sales Channels
7.4.2 C13 Stable Isotope Labeled Biomolecules Distributors
7.5 C13 Stable Isotope Labeled Biomolecules Customers
8 C13 Stable Isotope Labeled Biomolecules Market Dynamics
8.1 C13 Stable Isotope Labeled Biomolecules Industry Trends
8.2 C13 Stable Isotope Labeled Biomolecules Market Drivers
8.3 C13 Stable Isotope Labeled Biomolecules Market Challenges
8.4 C13 Stable Isotope Labeled Biomolecules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
